PUBLICATIONS

Last update : 08/08/2026
  • Fischer, B., Uchański,T., Sheryazdanova,A., Gonzalez,S., Volkov,A.N., Brosens,E., Zögg, T., Kalichuk, V., Ballet, S., Versées, W., Sablina, A.A., Pardon, E., Wohlkönig, A., Steyaert, J. "Allosteric nanobodies to study the interactions between SOS1 and RAS" Nature Communications., 15: art.n° 6214. (2024).
  • Hartman, J.J., Hwee, D.T., Robert-Paganin, J., Chuang, C., Chin, E.R., Edell, S., Lee, K.H., Madhvani, R., Paliwal, P., Pernier, J., Sarkar, S.S., Schaletzky, J., Schauer, K., Taheri, K.D., Wang, J., Wehri, E., Wu, Y., Houdusse, A., Morgan, B.P., Malik, F.I. "Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy" Nature Cardiovascular Research., 3(8): 1003–1016. (2024).
  • Wallace, M.D. , Cuxart, I. , Roret, T., Guée, L., Debowski, A.W., Czjzek, M., Rovira, C., Stubbs, K.A. , Ficko-Blean, E. "Constrained Catalytic Itinerary of a Retaining 3,6-Anhydro-D-Galactosidase, a Key Enzyme in Red Algal Cell Wall Degradation". Angewandte Chemie International Edition, 63(43):art.n° e202411171. (2024).
  • Mance, L., Bigot, N., Sánchez, E.Z., Coste, F., Martín-González, N., Zentout, S., Biliškov, M., Pukało, Z., Mishra, A., Chapuis, C., Arteni, A.A., Lateur, A., Goffinont, S., Gaudon, V., Talhaoui, I., Casuso, I., Beaufour, M., Garnier, N., Artzner, F., Cadene, M., Suskiewicz, M.J. "Dynamic BTB-domain filaments promote clustering of ZBTB proteins" Molecular Cell., 84(13): 2490-2510. (2024).
  • Fernández, I., Saunders, N., Duquerroy, S., Bolland, W.H., Arbabian, A., Baquero, E., Blanc, C., Lafaye, P., Haouz, A., Buchrieser, J., Schwartz, O., Rey, F.A. "Structural basis of TMPRSS2 zymogen activation and recognition by the HKU1 seasonal coronavirus". Cell, 187(16):4246-4260. (2024).
  • Lagoutte, P., Bourhis, J.M., Mariano, N., Gueguen-Chaignon, V., Vandroux, D., Moali, C., Vadon-Le Goff, S. "Mono- and bi-specific nanobodies targeting the CUB domains of PCPE-1 reduce the proteolytic processing of fibrillar procollagens" Journal of Molecular Biology., 436(16): art.n° 168667. (2024).
  • Collie, G.W., Börjesson, U., Chen, Y., Dong, Z., Di Fruscia, P., Gohlke, A., Hoyle, A., Hunt, T.A., Jesani, M.H., Luo, H., Luptak, J., Milbradt, A.G., Narasimhan, P., Packer, M. , Patel, S., Qiao, J. , Storer, R.I., Stubbs, C.J., Tart, J., Truman, C., Wang, A.T. , Wheeler, M.G., Winter-Holt, J. "Fragment-Based Discovery of Novel MUS81 Inhibitors". ACS Medicinal Chemistry Letters, 15(7):1151–1158. (2024).
  • Auguin, D., Robert-Paganin, J., Réty, S., Kikuti, C., David, A., Theumer, G., Schmidt, A.W., Knölker, H.J., Houdusse, A. "Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite opposite effects in heart contraction" Nature Communications., 15: art.n° 4885. (2024).
  • Dominguez-Molina, L., Kurata, T., Cepauskas, A., Echemendia-Blanco, D., Zedek, S., Talavera-Perez, A., Atkinson, G.C., Hauryliuk, V., Garcia-Pino, A. "Mechanisms of neutralization of toxSAS from toxin–antitoxin modules" Nature Chemical Biology., 21(2): 182–192. (2025).
  • Miron, S., Legrand, P., Dupaigne, P., van Rossum-Fikkert, S.E., Ristic, D., Majeed, A., Kanaar, R., Zinn-Justin, S., Zelensky, A.N. "DMC1 and RAD51 bind FxxA and FxPP motifs of BRCA2 via two separate interfaces ". Nucleic Acids Research, 52(12):7337–7353. (2024).